combination drug: |
amphetamine / dextroamphetamine |
- mixed amphetamine salts
- MEDLINEplus® Drug Information
U.S. Preparations:
- Adderall® (Shire) FDA approved indications:
"approval" 1.19.1960
"formulation revision review" treatment of Attention Deficit Hyperactivity Disorder (ADHD), narcolepsy 2.13.1996
US prescribing information
- Adderall XR™ (Shire) FDA approved indications:
treatment of Attention Deficit Hyperactivity Disorder (ADHD) 10.11.01
in adults 8.11.2004
in adolescents 7.21.2005
US prescribing information